Citra-Lock™ S

The safe & effective way to lock every central catheter 

Catheter lock solution, anti-clotting and antimicrobial is one of the innovations from Dirinco

Citra-Lock™ is recommended in the European Renal Best Practice Guidelines (ERBP) and the American Society of Diagnostic and Interventional Nephrology (ASDIN).

  • Citra locks have been extensively studied.
  • Citra-Lock™ is effective in maintaining catheter patency.

Clinical advantage of Citra-Lock™

  • safe
  • avoids heparin-associated bleeding
  • improves reliability of INR assyas (prothrombin time – time/international normalised ratio)
  • safe for heparin induced thrombocytopenia (HIT patients)
  • no side effects
  • reduction of tPA use
  • better outcomes over catheter exchange
  • reduces biofilm
  • reduction of hospitalisation
  • cost efficient

 The Citrate lock is based on tri-sodium citrate and can be safely used in all catheters!

  • Citra-Lock™ 5ml vials 4% – 30% -46,7%
  • Citra-Lock™S 2 x 2,5 ml (prefilled syringe) 4%

 Citra-Lock™S prefilled syringe

Citra-Lock™ 4%
Twin-Pack, 2 x 2,5 ml in 5 ml syringe. 24060207

Citra-Lock superior to taurolock

More efficient than Taurolidine-based Locking Solutions to prevent Thrombotic Dysfunction of Tunnelled Hemodialyse Catheters: a Retrospective Cohort Study.

Always Innovating

We are an independent company, with more than three decades of experience in marketing healthcare products.
With its roots in haemodialysis, Dirinco has become an expert in extracorporeal circulation treatment of renal failure and catheter lock solutions.